EM Vivas · Pelvic inflammatory disease
PID regimens, TOA, and partner treatment
Clinical viva on CDC PID care, antibiotics, and TOA escalation.
On this page
Study tools
Target exams
Interpretation
Reveal interpretationShowHide
PID is a clinical diagnosis. Minimum criteria: cervical motion, uterine, or adnexal tenderness with no competing diagnosis — treat empirically.[1]
Outpatient: ceftriaxone 500 mg IM once (1 g if weight >150 kg) + doxycycline 100 mg BD for 14 days + metronidazole 500 mg BD for 14 days.[1][2]
Admit and 72-hour failure: pregnancy, TOA, severe illness/peritonitis/sepsis, unable to tolerate orals, uncertain surgical diagnosis, failed OP therapy — admit, IV antibiotics, image for TOA, gynae drainage if indicated; always arrange partner treatment and STI follow-up. Persistent symptoms need M. genitalium testing and resistance-aware management — doxycycline is relatively poor for M. genitalium, and resistance-guided therapy outperforms empirical treatment.[1][4]
[4]References4ShowHide
- [1]Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recommendations and Reports, 2021.PMID 34292926
- [2]Ross J, Guaschino S, Cusini M, et al. 2017 European guideline for the management of pelvic inflammatory disease. International Journal of STD and AIDS, 2018.PMID 29198181
- [3]Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) randomized trial. American Journal of Obstetrics and Gynecology, 2002.PMID 12015517
- [4]Couldwell DL, Lewis DA. Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations Infect Drug Resist, 2015.PMID 26060411